Haemophilia : the official journal of the World Federation of Hemophilia · 2025
Five-Year Experience of Haemophilia Centre Certification Performed by the German, Austrian and Swiss Society for Thrombosis and Haemostasis Research.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Eichler Hermann, Bönigk Hagen, Halimeh Susan, Hart Christina, Hörner Judith, Klamroth Robert, Knöfler Ralf, Königs Christoph, Lang Thomas, Langer Florian, Miesbach Wolfgang, Oldenburg Johannes, Oral Ramona, Olivieri Martin, Pfrepper Christian, Pilch Jan, Scholz Ute, Streif Werner, Albisetti Manuela
Аннотация
INTRODUCTION: To enhance the treatment quality in haemophilia centres (HC), the German, Austrian and Swiss Society for Thrombosis and Haemostasis Research (GTH) started in 2017 the development of guidelines to define the structural and process quality of HC, essentially related to the EUHANET guidelines.
AIM: A certification process for HC located in Germany, Austria and Switzerland started in 2019.
METHODS: Within the first 5 years, 17 Haemophilia Comprehensive Care Centres (HCCC; ≥ 40 patients with severe HaemA/HaemB or vWD Type 3) and 6 Haemophilia Treatment Centres (HTC; ≥ 10 patients) were certified following a 1-day on-site audit performed by two trained haemophilia doctors. Experienced quality management staff supported the audit preparation in the HC. The entire certification process was coordinated by the accredited certification body ClarCert.
RESULTS: In the vast majority of the HCs, the precise specifications of the GTH guidelines in combination with the intensive audit preparation resulted in a mean number of only 2.80 nonconformities per audit (range 0-14). In addition, a mean number of 5.96 (range 2-13) recommendations were documented by the auditors. The feedback of the centres showed a high level of satisfaction with an excellent rating for both the professional auditors and ClarCert as the organizing certification body.
CONCLUSION: After the successful implementation of the certification process, a certificate is now an essential prerequisite for HC in Germany to conclude separate contracts regarding comprehensive care with health insurance bodies.
AIM: A certification process for HC located in Germany, Austria and Switzerland started in 2019.
METHODS: Within the first 5 years, 17 Haemophilia Comprehensive Care Centres (HCCC; ≥ 40 patients with severe HaemA/HaemB or vWD Type 3) and 6 Haemophilia Treatment Centres (HTC; ≥ 10 patients) were certified following a 1-day on-site audit performed by two trained haemophilia doctors. Experienced quality management staff supported the audit preparation in the HC. The entire certification process was coordinated by the accredited certification body ClarCert.
RESULTS: In the vast majority of the HCs, the precise specifications of the GTH guidelines in combination with the intensive audit preparation resulted in a mean number of only 2.80 nonconformities per audit (range 0-14). In addition, a mean number of 5.96 (range 2-13) recommendations were documented by the auditors. The feedback of the centres showed a high level of satisfaction with an excellent rating for both the professional auditors and ClarCert as the organizing certification body.
CONCLUSION: After the successful implementation of the certification process, a certificate is now an essential prerequisite for HC in Germany to conclude separate contracts regarding comprehensive care with health insurance bodies.